(Q30634842)

25 June 2017

title

The importance of health-related quality-of-life data in determining the value of drug therapy (English)

1 reference

25 June 2017

1 reference

Badia X

1

1 reference

25 June 2017

Herdman M

series ordinal

2

1 reference

25 June 2017

publication date

1 January 2001

1 reference

25 June 2017

published in

Clinical Therapeutics

1 reference

25 June 2017

volume

23

1 reference

25 June 2017

issue

1

1 reference

25 June 2017

page(s)

168-175

1 reference

Shattuck lecture--outcomes management. A technology of patient experience

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Comparison of health outcomes at a health maintenance organisation with those of fee-for-service care

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Generic health measurement: past accomplishments and a measurement paradigm for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Quality of life in arthritis patients using nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Integrating response shift into health-related quality of life research: a theoretical model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Interpreting treatment effects in randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Multi-attribute health status classification systems. Health Utilities Index

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

Methodology for measuring health-state preferences--II: Scaling methods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980039-4

7 January 2021

10.1016/S0149-2918(01)80039-4

Identifiers

DOI

1 reference

25 June 2017

1 reference